Prismatic Adaptation for Rehabilitation of Postural Imbalance After Stroke (PEQUIE)

March 28, 2022 updated by: Hospices Civils de Lyon

Assessment of the Rehabilitation of Postural Imbalance After Chronic Right Supratensorial Stroke by Prismatic Adaptation: Multicentric Randomised Sham-controlled Trial

Postural imbalance after stroke leads to limitations of activity and a worse autonomy. The postural imbalance is increased in right supratensorial stroke (RSS) compared to left supratensorial stroke. The evidences for the rehabilitation of postural imbalance are weak.

Likewise, disorders of spatial reference frames are increased in RSS. The postural imbalance is correlated with the disorders of spatial reference frames in RSS patients.

Prismatic adaptation (PA) is often used for the rehabilitation of unilateral spatial neglect after RSS. Several studies have demonstrated a peculiar expansion of sensorimotor after-effects to spatial cognition. An immediate effect of reduction in postural imbalance have been showed in acute RSS. Therefore, it is interested to investigate the immediate and delayed effects of PA on the postural balance and the spatial reference frames in chronic RSS to purpose a new therapeutic approach.

The hypothesis of the study is that PA would improve the postural balance (activity) of chronic RSS patients by a reduction in mediolateral postural asymmetry, resulting from a " bottom-up " action of PA on spatial reference frames.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Grenoble, France
        • Not yet recruiting
        • CHU Grenoble
        • Contact:
        • Principal Investigator:
          • DOMINIC PERENNOU, MD
      • Saint-Genis-Laval, France, 69230
        • Recruiting
        • Hôpital Henry Gabrielle, service de médecine physique et réadaptation
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Gilles RODE, MD
        • Principal Investigator:
          • Amandine GUINET-LACOSTE, MD
        • Sub-Investigator:
          • Jacques LUAUTE, MD
        • Sub-Investigator:
          • Yves ROSSETTI, MD
        • Sub-Investigator:
          • Julie DI MARCO, MD
      • Saint-Étienne, France
        • Not yet recruiting
        • CHU Saint-Etienne
        • Contact:
        • Principal Investigator:
          • Pascal GIRAUX, MD
        • Sub-Investigator:
          • Paul CALMELS, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult, over 18 years old, and less than 80 years old
  • Stroke

    • right
    • supratensorial,
    • unilateral,
    • haemorrhagic or ischemic,
    • chronic (over 12 months)
  • Ability to stay over 30 seconds in standing static position with open eyes and close eyes
  • Show a postural imbalance, determined by a body weight bearing on right lower limb ≥ 60% during at least one posturographic evaluation with open eyes and that requires an inpatient rehabilitation
  • Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research
  • Free, enlightened and written consent of the patient

Exclusion Criteria:

  • Cerebellar lesion
  • Brainstem lesion
  • Bilateral cerebral lesion
  • All orthopaedic or rheumatologic diseases, retinal visual impairments or other diseases interfering with assessments in accordance with the investigator's judgment
  • Pregnancy or breast feeding
  • Under an administrative or legal supervision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prismatic adaptation (PA) group
Patients in the experimental group will benefit from 10 sessions of adaptation prismatic (PA) by means of one daily session of 20 minutes (5 times by week; 2 weeks), performed by an experienced physical therapist or occupational therapist. All patients will also benefit from conventional rehabilitation (Standard physical therapy, standard occupational therapy, standard speech therapy …) according to the needs of the patients.
Prismatic adaptation (PA) is based on the wearing of a pair of glasses producing a visual field deviation of 10° to rightward. While wearing theses glasses, the patient is asked to perform fast pointing movements towards targets by the right hand. Targets are symmetrical located at 10° in the right and left side in front of the patient. The order of pointing between these two targets is pseudo-randomly by the therapist. At the beginning of the exposure, the patient performs pointing movements with a shift toward the right side (initial errors consecutive to the prism deviation). Taking into account theses errors, the patient then compensates the optical deviation. After removing the prismatic glasses, the asked pointing movement to the targets is once again shifted but to the left side this time (after-effects attesting the prismatic adaptation)
Placebo Comparator: Sham group
Patients in the sham group will benefit from 10 sessions of sham adaptation prismatic (S-PA) by means of one daily session of 20 minutes (5 times by week; 2 weeks), performed by an experienced physical therapist or occupational therapist. All patients will also benefit from conventional rehabilitation (Standard physical therapy, standard occupational therapy, standard speech therapy …) according to the needs of the patients.

The sham prismatic adaptation (S-PA) is based on the wearing of a pair of glasses producing no visual field deviation. Theses sham glasses is identical with theses used in PA group without the optical deviation. The conditions are similar with theses in the PA group.

The procedure with the sham glasses are similar with these one used in the PA group: While wearing the sham glasses, the patient is asked to perform fast pointing movements towards targets by the right hand. Targets are symmetrical located at 10° in the right and left side in front of the patient. The support with targets are the same as these one used in the PA group. The order of pointing between these two targets is pseudo-randomly by the therapist. At the beginning of the exposure, the patient performs pointing movements without shift. No compensation of movement is observed. After removing the prismatic glasses, the asked pointing movement to the targets is not shifted (No after-effects observed)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance: The inter-group difference of within-group changes for the Berg Balance Scale (BBS)
Time Frame: Change from baseline (mean of the 2 pre-tests) at 7 days after the end of treatment (3 weeks about after the baseline)
Balance : The inter-group difference of within-group changes for the Berg Balance Scale (BBS) Score between 0 and 56 points
Change from baseline (mean of the 2 pre-tests) at 7 days after the end of treatment (3 weeks about after the baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance: the inter-group difference of within-group changes for the Berg Balance Scale (BBS)
Time Frame: Change from baseline at 1 month after the end of treatment
Change from baseline (mean of the 2 pre-tests) at one month after the end of treatment (M+1) (1 month and 2 weeks about after the baseline) and at three months after the end of treatment (M+3) (3 month and 2 weeks about after the baseline) Score between 0 and 56 points.
Change from baseline at 1 month after the end of treatment
Balance: The inter-group difference of within-group changes for standing static posturographic variables
Time Frame: Change from baseline at +2 Hours, Day 3, Day7, Month +1 and Month +3 after the end of treatment

Satnding posturographic variables include mediolateral and anteroposterior deviation of center of pression (COP), mediolateral and anteroposteriorvariability of COP, sway area of COP, body weight bearing on each lower limb.

The mediolateral and anteroposterior deviations of COP measured in millimeters, the sway area of COP calculated in square millimeters, the mediolateral and anteroposterior variability of COP calculated as the standard deviation of the mediolateral and anteroposterior deviations of COP, body weight bearing on each lower limb measured in percent of total weight bearing.

Change from baseline at +2 Hours, Day 3, Day7, Month +1 and Month +3 after the end of treatment
Lateropulsion: The inter-group difference of within-group changes for the Scale for Contraversive Pushing (SCP)
Time Frame: Change from baseline at +2 Hours, Day 3, Day7, Month +1 and Month +3 after the end of treatment.
Score between 0 and 6 points
Change from baseline at +2 Hours, Day 3, Day7, Month +1 and Month +3 after the end of treatment.
The inter-group difference of within-group changes for each spatial reference frame (MSSA, VSSA, OLP, LBA)
Time Frame: Change from baseline at +2 Hours, Day 3, Day 7, Month 1 and Month 3 after the end of treatment
Spatial reference frames include the measurement of the manual subjective straight aheaed (MSSA), the visual subjective straight ahead (VSSA), open-loup pointing without visual feedback (OLP), the subjective longitudinal body axis (LBA) Angular deviation measured in degrees
Change from baseline at +2 Hours, Day 3, Day 7, Month 1 and Month 3 after the end of treatment
Autonomy : Inter-group difference of within-group changes for the Barthel index (BI)
Time Frame: Change from baseline (pre-test) at Day7, Month +1 and Month +3 after the end of treatment.
Score between 0 and 100 points
Change from baseline (pre-test) at Day7, Month +1 and Month +3 after the end of treatment.
Additionnal descriptive anatomic study of cerebral lesions using diffusion tensor Magnetic Resonance Imaginig (MRI) (Tractography)
Time Frame: Before the starting of the intervention, during the pre-tests.
To determine the location of the cerebral lesion, the size of cerebral lesion and to quantify the severity of the disconnection (after tractography reconstructions of white matter pathways).
Before the starting of the intervention, during the pre-tests.
Relationship between prismatic adaptation induced changes on misperceptions of spatial reference frames and these on postural and balance disorders
Time Frame: +2Hours, Day+3, Day+7, Month+1 and Month+3.
Statistical correlations between changes (before versus after intervention) on Berg Balance Scale (BBS), postural disorders (i.e. Weight Beainf Asymetry (WBA), body sway, and lateropulsion), and spatial reference frames.
+2Hours, Day+3, Day+7, Month+1 and Month+3.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 4, 2017

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

April 1, 2024

Study Registration Dates

First Submitted

May 12, 2017

First Submitted That Met QC Criteria

May 12, 2017

First Posted (Actual)

May 16, 2017

Study Record Updates

Last Update Posted (Actual)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 28, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Right Supratensorial Stroke Patients

Clinical Trials on The prismatic adaptation (PA)

3
Subscribe